DR. ERNESTO BUSTINZA LINARES (M.D.) – Hematology & Oncology Physician, NPI 1598966509
Hematology & Oncology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
1,007 HEMATOLOGY/ONCOLOGY in FL
Provider Addresses for DR. ERNESTO BUSTINZA LINARES (M.D.)
805 Currency Cir
Lake Mary, FL 327462115
Phone: (407) 804-6133
Fax: (866) 447-9143
Type: Location
Veronica S Shoemaker Blvd, Fort Myers, Lee County, Florida, 33916, United States
ATTN: CREDENTIALING DEPT.
FORT MYERS, FL 339162216
Phone: (239) 274-8200
Fax: (239) 278-3350
Type: Mailing
917, Rinehart Road, Lake Mary, Seminole County, Florida, 32746, United States
SUITE 2041
LAKE MARY, FL 327464802
Phone: (407) 804-6133
Fax: (321) 283-4332
Type: Location
PO BOX 102222
ATTN: CREDENTIALING DEPT.
ATLANTA, GA 303682222
Phone: (239) 274-8200
Type: Mailing
810 N SPRING GARDEN AVE STE 100
DELAND, FL 327203106
Phone: (386) 943-9446
Fax: (386) 943-9385
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 311 Open Payments records for all available years, with a total value of $6,657.
Total Amount is formed as General ($6,657) + Research ($0) + Ownership ($0) = $6,657.
Last reported payment date: 2024-12-17 • Largest payer in this snapshot: Novartis Pharmaceuticals Corporation ($899).
Total Amount
$6,657
General + Research + Ownership
Payments
311
Total payment records
General Amount
$6,657
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-17
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Novartis Pharmaceuticals Corporation | $899 |
| Celgene Corporation | $622 |
| Gilead Sciences, Inc. | $340 |
| Amgen Inc. | $258 |
| Pharmacyclics LLC, an AbbVie Company | $236 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2014-09-19
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20140919002359 | I | Hematology/Oncology | FL | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 58,650 | 56 | $0 |
| J1756 | Injection, iron sucrose, 1 mg | 12,800 | 22 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 8,190 | 19 | $0 |
| J0897 | Injection, denosumab, 1 mg | 6,420 | 47 | $0 |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 4,090 | 33 | $0 |
Insurance plans in this area (ZIP 32746)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| HEMATOLOGY/ONCOLOGY | FL | 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | 268 | 61 |
| HEMATOLOGY/ONCOLOGY | FL | 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 92 | 27 |
Group practice members
| Name | Specialty | State |
|---|---|---|
| Medical Oncology | FL | |
| Medical Oncology, Hematology/Oncology | FL | |
| H E M A T O L O G Y/ O N C O L O G Y | FL | |
| H E M A T O L O G Y/ O N C O L O G Y | FL | |
| Internal Medicine, Hematology/Oncology | FL | |
| - | GA | |
| Hematology/Oncology, Internal Medicine | GA | |
| H E M A T O L O G Y/ O N C O L O G Y | FL | |
| Hospice/Palliative Care, Internal Medicine | FL | |
| H E M A T O L O G Y/ O N C O L O G Y | GA |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.